期刊文献+

不动杆菌属的耐药性分析 被引量:37

Antimicrobial resistance of Acinetobacter isolates
在线阅读 下载PDF
导出
摘要 目的了解湖北地区不动杆菌属耐药现状及变化趋势,并探讨不同来源菌株耐药率间的差别。方法采用纸片扩散法检测药物敏感度,协同法过筛试验检测金属β内酰胺酶(MBL)。结果2000-2004年分离的2 829株不动杆菌属的主要来源为痰。抗菌作用最强的抗菌药物为亚胺培南,其次是头孢哌酮-舒巴坦,ICU菌株的耐药性明显高于非ICU患者和门诊患者(P>0.05)。除第一代、第二代头孢菌素、头孢哌酮和氨曲南外,非ICU患者和门诊患者对其余抗菌药物耐药率均较低,分别在40%和20%以下。15种常用抗菌药物耐药率总体呈上升趋势,尤其细菌对头孢他啶、阿米卡星、环丙沙星等以往作用较好的药物的耐药率增高更为显著。从我院2004年1-9月分离的37株耐亚胺培南鲍曼不动杆菌中筛选出8株细菌产MBL。结论门诊患者、非ICU患者I、CU患者所分离的不动杆菌耐药率间存在差别,对临床经验用药具有一定指导意义。产MBL可能是湖北地区不动杆菌属耐亚胺培南的重要原因。 Objective To analyze the resistance pattern and trend in Acinetobacter strains isolated from 15 tertiary hospitals of Hubei province from 2000 through 2004, and study the difference in resistance rate of isolates from different wards. Methods The susceptibility was tested by K-B method. The synergetic screening test was applied to detect metallo-β-lactamases. Results The main source of 2 829 isolates was sputum, accounting for 74. 4%. Imipenem was the most active antibiotic tested, to which up to 90% to all isolates were susceptible, followed by cefoperazone-sulbactam. Isolates from ICU were more resistant to all antimicrobials than those from out-patients and non-ICU inpatients. The isolates from non-ICU inpatients and out-patients were less resistant to other antimicrobials but cefazolin, cefuroxime, cefoperazone and aztronam, with resistance rate of less than 40% and 20% respectively. The trend of the resistance to 15 commonly used antibiotics was going up in general, especial- ly ceftazidime, amikacin and ciprofloxacin. Eight metallo-β-lactamase-producing strains were screened out from 37 strains of Acinetobacter baumannii resistant to imipenenm, which were isolated from Tongji Hospital between January and September in 2004. Conclusions It is valuable for empiric antimicrobial therapy to analyze the differential resistance rate in Acinetobacter spp. isolates from out-patients, non-ICU inpatients and ICU patients. Production of metallo-β-lactamases may be one of the important reasons underlying the resistance of Acinetobacler spp. to imipenem in Hubei province.
出处 《中国抗感染化疗杂志》 CAS 2005年第6期342-345,共4页 Chinese Journal of Infection and Chemotherapy
关键词 不动杆菌属 耐药性 金属Β内酰胺酶 Acinetobacter spp Antibiotic resistance Metallo-β-lactamase
  • 相关文献

参考文献7

  • 1Afzal-Shah M,Livermore DM.Worldwide emergence of carbapenem-resistant Acinetobacter spp[J].J Antimicrob Chemother,1998,41:576-577.
  • 2Brisse S,Milatovic D,Fluit AC,et al.Molecular surveillance of European quinolone-resistant clinical isolates of Pseudomonas aeruginosa and Acinetobacter spp using automated ribotyping[J].J Clin microbial,2000,38:3636-3645.
  • 3Larson EL.Persistent carriage of gram-negative bacteria on hands[J].Am J Infect Control,1981,9:112-119.
  • 4Lee K,Lim YS,Yong D,et al.Evaluation of the Hodge test and imipenem-EDTA double-disk synergy test for differentiating metallo-β1actamaseproducing isolates of Pseudomonas spp.and Acinetobacter spp.[J].J Clin Microbiol,2003,41:4623-4629.
  • 5程曦,曾蔚,贾文祥.鲍氏不动杆菌耐药的主要机制[J].国外医药(抗生素分册),2003,24(2):63-64. 被引量:55
  • 6Yum JH,Yi K,Lee H,et al.Molecular characterization of metallo-βlactamase-producing Acinetobacter baumannii and Acinetobacter genomospecies 3 from Korea:identification of two integrons carrying the blaVIM-2 gene cassettes[J].J Antimicrob Chemother,2002,49,837-840.
  • 7Towner KJ.Clinical importance and antibiotic resistance of Acinetobacter spp.Proceedings of a symposium held on 4-5November 1996 at Eilat,Israel[J].J Med Microbial,1997,46:721-746.

二级参考文献5

  • 1[1]Brisse S, Milatovic D, Fluit A C. Molecular surveillance of European quinolone-resistant clinical isolates of Pseudomonas aeruginosa and Acinetobacter spp using automated ribotyping [J]. J Clin Microbiol, 2000,38 (10): 3636
  • 2[2]Afzal-Shah M, Livermore D M. Worldwide emergence of carbapenem-resistant Acinetobacter spp[J] . J Antimicrob Chemother , 1998,41:576
  • 3[3]Robert E W. Resistant mechanisms in Pseudomonas aeruginosa and other nonfermentative gram-negative bacteria [J]. Clin Infect Dis, 1998,27(Suppll): S93
  • 4[4]Bou G, Oliver A, Martinez-Beltran J. OXA-24, a novel class D β-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain [J]. Antimicrob Agents Chemother, 2000,44(6):1556
  • 5[5]Fernandez-viladrich P, Corbella X, Corral L, et al. Successful treatment of ventriculitis due to carbapenem-resistant Acinetobacter baumanniiwith intraventricular colistim sulfomethate sodium[J].Clin Infect Dis, 1999,28(4) :916

共引文献54

同被引文献296

引证文献37

二级引证文献206

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部